vs
Side-by-side financial comparison of HEARTLAND EXPRESS INC (HTLD) and Protagonist Therapeutics, Inc (PTGX). Click either name above to swap in a different company.
HEARTLAND EXPRESS INC is the larger business by last-quarter revenue ($179.4M vs $170.6M, roughly 1.1× Protagonist Therapeutics, Inc). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs -10.8%, a 88.0% gap on every dollar of revenue. On growth, Protagonist Therapeutics, Inc posted the faster year-over-year revenue change (184.4% vs -26.1%). Protagonist Therapeutics, Inc produced more free cash flow last quarter ($182.8M vs $-44.2M).
Heartland Express is an American trucking company headquartered in North Liberty, Iowa. The company offers truckload shipping services across the United States.
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.
HTLD vs PTGX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $179.4M | $170.6M |
| Net Profit | $-19.4M | $131.7M |
| Gross Margin | — | — |
| Operating Margin | -12.7% | 74.3% |
| Net Margin | -10.8% | 77.2% |
| Revenue YoY | -26.1% | 184.4% |
| Net Profit YoY | -949.2% | 381.7% |
| EPS (diluted) | $-0.24 | $2.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $179.4M | — | ||
| Q3 25 | $196.5M | — | ||
| Q2 25 | $210.4M | — | ||
| Q1 25 | $219.4M | — | ||
| Q4 24 | $242.6M | $170.6M | ||
| Q3 24 | $259.9M | — | ||
| Q2 24 | $274.8M | — | ||
| Q1 24 | $270.3M | $255.0M |
| Q4 25 | $-19.4M | — | ||
| Q3 25 | $-8.3M | — | ||
| Q2 25 | $-10.9M | — | ||
| Q1 25 | $-13.9M | — | ||
| Q4 24 | $-1.9M | $131.7M | ||
| Q3 24 | $-9.3M | — | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $-15.1M | $207.3M |
| Q4 25 | -12.7% | — | ||
| Q3 25 | -3.7% | — | ||
| Q2 25 | -5.9% | — | ||
| Q1 25 | -6.8% | — | ||
| Q4 24 | 0.4% | 74.3% | ||
| Q3 24 | -2.7% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | -5.3% | 80.9% |
| Q4 25 | -10.8% | — | ||
| Q3 25 | -4.2% | — | ||
| Q2 25 | -5.2% | — | ||
| Q1 25 | -6.3% | — | ||
| Q4 24 | -0.8% | 77.2% | ||
| Q3 24 | -3.6% | — | ||
| Q2 24 | -1.3% | — | ||
| Q1 24 | -5.6% | 81.3% |
| Q4 25 | $-0.24 | — | ||
| Q3 25 | $-0.11 | — | ||
| Q2 25 | $-0.14 | — | ||
| Q1 25 | $-0.18 | — | ||
| Q4 24 | $-0.03 | $2.01 | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.19 | $3.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.5M | $418.9M |
| Total DebtLower is stronger | $154.1M | — |
| Stockholders' EquityBook value | $755.3M | $675.3M |
| Total Assets | $1.2B | $744.7M |
| Debt / EquityLower = less leverage | 0.20× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.5M | — | ||
| Q3 25 | $32.7M | — | ||
| Q2 25 | $22.9M | — | ||
| Q1 25 | $23.9M | — | ||
| Q4 24 | $12.8M | $418.9M | ||
| Q3 24 | $30.7M | — | ||
| Q2 24 | $23.9M | — | ||
| Q1 24 | $23.8M | $322.6M |
| Q4 25 | $154.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $187.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $755.3M | — | ||
| Q3 25 | $775.6M | — | ||
| Q2 25 | $786.7M | — | ||
| Q1 25 | $807.7M | — | ||
| Q4 24 | $822.6M | $675.3M | ||
| Q3 24 | $825.7M | — | ||
| Q2 24 | $836.8M | — | ||
| Q1 24 | $848.8M | $560.4M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | $744.7M | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.5B | $629.3M |
| Q4 25 | 0.20× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.23× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.9M | $184.2M |
| Free Cash FlowOCF − Capex | $-44.2M | $182.8M |
| FCF MarginFCF / Revenue | -24.6% | 107.1% |
| Capex IntensityCapex / Revenue | 33.0% | 0.8% |
| Cash ConversionOCF / Net Profit | — | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $-66.9M | $101.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.9M | — | ||
| Q3 25 | $27.5M | — | ||
| Q2 25 | $21.0M | — | ||
| Q1 25 | $25.8M | — | ||
| Q4 24 | $37.8M | $184.2M | ||
| Q3 24 | $35.6M | — | ||
| Q2 24 | $40.0M | — | ||
| Q1 24 | $31.0M | $-27.4M |
| Q4 25 | $-44.2M | — | ||
| Q3 25 | $-12.2M | — | ||
| Q2 25 | $-12.8M | — | ||
| Q1 25 | $2.3M | — | ||
| Q4 24 | $-45.5M | $182.8M | ||
| Q3 24 | $24.6M | — | ||
| Q2 24 | $29.4M | — | ||
| Q1 24 | $26.3M | $-27.7M |
| Q4 25 | -24.6% | — | ||
| Q3 25 | -6.2% | — | ||
| Q2 25 | -6.1% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | -18.8% | 107.1% | ||
| Q3 24 | 9.5% | — | ||
| Q2 24 | 10.7% | — | ||
| Q1 24 | 9.7% | -10.9% |
| Q4 25 | 33.0% | — | ||
| Q3 25 | 20.2% | — | ||
| Q2 25 | 16.1% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | 34.3% | 0.8% | ||
| Q3 24 | 4.2% | — | ||
| Q2 24 | 3.8% | — | ||
| Q1 24 | 1.7% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
